SEC Form 4 · accession 0001437749-19-000189
Oxford Immunotec Global PLC · OXFD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Richard M. Altieri
Officer — Chief Financial Officer
Period of report
Jan 1, 2019
Accepted (ET)
Jan 3, 2019 · 4:30 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001586049
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF1 | Jan 1, 2019 | F | 716 | $12.78 | D | 210,175 | D | |
| Ordinary SharesF2 | Jan 1, 2019 | F | 1,021 | $12.78 | D | 209,154 | D | |
| Ordinary SharesF3 | Jan 1, 2019 | F | 1,189 | $12.78 | D | 207,965 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents shares withheld to pay withholding taxes upon vesting of restricted share units originally granted on June 19, 2015. The number of shares withheld was determined based on the closing price on the last prior trading day which was December 31, 2018.
- F2Represents shares withheld to pay withholding taxes upon vesting of restricted share units originally granted on March 4, 2016. The number of shares withheld was determined based on the closing price on the last prior trading day which was December 31, 2018.
- F3Represents shares withheld to pay withholding taxes upon vesting of restricted share units originally granted on February 24, 2017. The number of shares withheld was determined based on the closing price on the last prior trading day which was December 31, 2018.